Orthofix Medical Inc. (NASDAQ: OFIX) is a Healthcare company (Medical - Devices) with a market capitalization of $272M. The Maz Rating grades it against the other companies in its sector.
Orthofix Medical Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $6.67, Orthofix Medical Inc. trades at 0.3x sales and 0.6x book value, with an EV/EBITDA of 4.4. Over the last twelve months it generated about $834M of revenue and a net loss of $45M. It runs a gross margin of 69.2%, an operating margin of -0.6% and a net margin of -5.4%. It shows return on equity of -10.3%, return on invested capital of -0.8% and a free cash flow yield of -16.1%. On the balance sheet: a debt-to-equity ratio of 0.55 and a current ratio of 3.11. Over the past 52 weeks the share price ranged from $6.52 to $16.42, with a beta of 0.64.
Orthofix Medical Inc. does not currently pay a dividend.
17 Wall Street analyst ratings cover the stock: 8 Buy and 9 Hold, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.